Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks

NCT00781560 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00781560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00781560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2009
Enrollment
2,575 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia